Nektar Therapeutics reported $137.92M in Operating Expenses for its fourth fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Agios Pharmaceuticals AGIO:US $ 99.27M 2.91M
Amgen AMGN:US $ 3.74B 804M
Astrazeneca AZN:US 10.51B 1.79B
Baxter International BAX:US $ 3544M 376M
Biocryst Pharmaceuticals BCRX:US $ 99.88M 56.38M
Biogen BIIB:US $ 1921.1M 225.6M
Bluebird Bio BLUE:US $ 122.29M 14.98M
Bristol Myers Squibb BMY:US $ 9.1B 247M
Cara Therapeutics CARA:US $ 32.7M 1.64M
Dr.Reddys Laboratories DRRD:IN 53.17B 9B
Eisai 4523:JP Y 211704M 22380M
Eli Lilly And LLY:US $ 5405.7M 677M
Esperion Therapeutics ESPR:US $ 61.82M 9.2M
Exelixis EXEL:US $ 272.74M 61.76M
Gilead Sciences GILD:US $ 6393M 89M
GlaxoSmithKline GSK:LN 6.98B 1.65B
Halozyme Therapeutics HALO:US $ 41.61M 3.86M
Immunogen IMGN:US $ 60.93M 1.62M
Ironwood Pharmaceuticals IRWD:US $ 39.68M 20.86M
Karyopharm Therapeutics KPTI:US $ 82.26M 2.95M
Merk MRK:US $ 10332M 386M
Mirati Therapeutics MRTX:US $ 184.93M 12.45M
Nektar Therapeutics NKTR:US $ 137.92M 598K
Novartis NOVN:VX 9.96B 998M
Sarepta Therapeutics SRPT:US $ 297.71M 9.56M
Seattle Genetics SGEN:US $ 559.51M 42.41M
Takeda 4502:JP 874.91B 90.1B
Teva Pharmaceutical TEVA:IT 4.37B 352M
Xencor XNCR:US $ 59.03M 3.13M
YTE INCY:US $ 616.69M 135.42M